Page last updated: 2024-12-07

1,n(6)-ethenoadenosine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

You are likely referring to **1,N⁶-ethenoadenosine**, not 1,n(6)-ethenoadenosine.

**1,N⁶-ethenoadenosine** is a **deoxyadenosine analog** that is formed by the reaction of adenosine with **ethylene oxide**. It is a **mutagenic** compound, meaning it can induce mutations in DNA.

Here's why 1,N⁶-ethenoadenosine is important for research:

* **DNA damage and repair:** It serves as a model compound for studying DNA damage caused by various environmental agents.
* **Mutagenesis:** Its mutagenic properties allow researchers to investigate the mechanisms of mutation formation and DNA replication errors.
* **Cancer research:** The mutagenic potential of 1,N⁶-ethenoadenosine makes it relevant to cancer research, as mutations are a hallmark of cancer.
* **Biomarker for environmental exposure:** Its presence in biological samples can indicate exposure to environmental toxins that can cause DNA damage.

**Here are some key points to remember:**

* 1,N⁶-ethenoadenosine is a **deoxyadenosine analog**.
* It is formed by the reaction of adenosine with **ethylene oxide**.
* It is a **mutagenic** compound.
* It is important for research related to **DNA damage, mutagenesis, cancer, and environmental exposure**.

**Note:** It is important to use the correct name, which is **1,N⁶-ethenoadenosine**. The N⁶ indicates that the ethylene oxide molecule is attached to the N6 position of the adenine base.

1,N(6)-ethenoadenosine: fluorescent probe; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID108175
MeSH IDM0050962

Synonyms (14)

Synonym
ccris 2745
3h-imidazo(2,1-i)purine, 3-beta-d-ribofuranosyl-
1,n6-ethenoadenosine
1,n(6)-ethenoadenosine
3-beta-d-ribofuranosylimidazo(2,1-i)purine
3-pentofuranosyl-3h-imidazo[2,1-i]purine
39007-51-7
n6-ethenoadenosine
(2r,3s,4r,5r)-2-(hydroxymethyl)-5-imidazo[2,1-f]purin-3-yloxolane-3,4-diol
1 n6-ethenoadenosine free base
AKOS030568250
DTXSID40959846
(2r,3s,4r,5r)-2-(hydroxymethyl)-5-(3h-imidazo[2,1-i]purin-3-yl)tetrahydrofuran-3,4-diol
(2r,3s,4r,5r)-2-(hydroxymethyl)-5-{3h-imidazo[2,1-f]purin-3-yl}oxolane-3,4-diol
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (46)

TimeframeStudies, This Drug (%)All Drugs %
pre-199023 (50.00)18.7374
1990's14 (30.43)18.2507
2000's7 (15.22)29.6817
2010's1 (2.17)24.3611
2020's1 (2.17)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.21

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.21 (24.57)
Research Supply Index3.89 (2.92)
Research Growth Index4.10 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.21)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other48 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]